Stay updated on Rucaparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA site-wide NIH notice about terminology during a website transition appears above the page, and the displayed site revision changes from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ARIEL3 study’s detailed content has been removed and the page now shows a 403 Forbidden error, replacing the study overview, criteria, outcomes, and contacts with an error page.SummaryDifference18%

- Check48 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing Revision: v3.6.6, indicating a new site version without altering the study details.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a new build of the page. The update does not alter the displayed study details or user-facing content.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor update to the page metadata.SummaryDifference0.0%

Stay in the know with updates to Rucaparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.